Group 1 - The core focus of the "Beijing Action Plan for Supporting the Development of Artificial Intelligence Applications in the Medical and Health Sector (2026-2027)" is on enhancing clinical diagnosis, grassroots health, and health management, while also expanding into public health management, intelligent management of medical institutions, industry regulation, and public-facing intelligent services [1] - The plan emphasizes the importance of not allowing artificial intelligence to completely replace the professional judgment of medical personnel, ensuring the rationality of medical decisions and humanistic care [1] - The plan aims to establish a governance system covering the entire data lifecycle and to create unified standards and norms for data generation, collection, aggregation, storage, and application [3] Group 2 - The plan encourages collaboration between medical institutions and high-quality AI companies for application research and development, promoting mature products across relevant medical institutions in the city [3] - The "Several Measures" document further proposes "medical-enterprise collaboration," highlighting the necessity of professional medical knowledge for data annotation and model validation [3][5] - The use of blockchain technology is proposed to create a trusted data space for healthcare, enabling model training in a secure environment and facilitating the conversion of data resources into economic value [7] Group 3 - Various levels of medical institutions in Beijing are applying AI products tailored to their specific needs, with examples including AI services in pre-hospital, in-hospital, and post-discharge follow-up processes [6] - AI technology is being promoted in grassroots medical institutions, with applications such as AI retinal imaging and pre-prescription review systems [6] - The collaboration among enterprises in the medical AI sector is deemed essential for sharing mature technologies and algorithms, thereby avoiding resource duplication and collectively advancing the industry [5]

Core Insights - The article discusses how Hainan Province is leveraging medical health data to enhance public welfare and promote the development of the biopharmaceutical industry in the Hainan Free Trade Port [1][2] Group 1: Medical Health Data Utilization - Hainan aims to balance public welfare and industrial development by authorizing the operation and value release of medical health data [1] - The province is focusing on four key areas: convenience for the public, government support, assistance for medical professionals, and industry promotion [1] - Hainan is implementing "Internet + Healthcare" strategies, creating services like "Haiyi Ban" and "Three Medical Health" to facilitate self-query of electronic health records and AI doctor services for residents [1] Group 2: Data Integration and Security - The "Three Medical Linkage One Network" has integrated 24.6 billion data entries from various medical institutions, with the first national "Three Medical Big Data Center" set to be established by December 10, 2025 [2] - Hainan has been proactive in data element layout, receiving approval for two significant national pilot projects related to trusted data spaces and high-quality data sets [2] - The province emphasizes high standards for data security and health privacy, implementing a "data available but not visible" policy to ensure compliance while maximizing data utility [2] Group 3: Future Directions - Hainan plans to focus on high-value application scenarios, accelerating the registration and trading of health data products [2] - The province aims to explore safe and compliant pathways for authorized development and operation in specific fields, contributing to the growth of the digital economy [2]